Cellix founder receives Trinity Innovation Award

Pictured: Vivienne Williams, Cellix & TCD Provost Dr Patrick Pendergast

17 January 2014

The Trinity Innovation Award was presented to entrepreneurial graduate and Cellix co-founder Vivienne Williams. Cellix Ltd a Trinity College Dublin spin-out company, developed technology that mimicks human capillaries in plastic with microfluidic pumping solutions.

The Trinity Innovation Award is an annual prize presented to an individual or company that has made an outstanding contribution to the promotion of an entrepreneurial culture within the University and society.

On presenting the award, Trinity Provost Dr Patrick Prendergast said: “Vivienne is an excellent example of an entrepreneurial graduate. Her innovative career path acts as an inspiration to our students; by achieving excellence in research and  exploiting its commercial potential  she now heads up a significant innovative company.

“Trinity is committed to enabling our students to create their own companies and jobs with long-term benefits for the economy and society. Our recently launched Strategy for Innovation and Entrepreneurship builds on our entrepreneurial culture, pioneering an integrated approach to innovation and entrepreneurship that will permeate all levels of education. It is forging an entrepreneurial campus, bringing forward a new generation of job creators that will create scalable businesses and sustainable jobs.”

On receiving the Award, Williams said: “I’m delighted to receive this award and believe that it marks our dedication to the development of innovative tools for drug discovery and development.”

Williams, the holder of an MSc in Physics from Trinity, began postgraduate research in microfluidics with physicist Prof Igor Shvets and former Prof of Medicine Dermot Kelleher in 1999. In 2006, Cellix was spun-out with Williams as CEO and co-founder Dmitry Kashanin as CTO.

Cellix has since expanded and relocated to an industrial facility in the greater Dublin area. It counts AstraZeneca, Pfizer, Sanofi-Aventis, Servier and Amgen among its clients.

TechCentral Reporters

Read More:

Leave a Reply

Back to Top ↑